EQT Co. (NYSE:EQT – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the sixteen ratings firms that are presently covering the company, Marketbeat Ratings reports. Eight analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $45.24.
Several brokerages have commented on EQT. The Goldman Sachs Group lowered their price objective on shares of EQT from $48.00 to $43.00 and set a “buy” rating for the company in a research report on Tuesday, April 2nd. Sanford C. Bernstein upgraded shares of EQT from an “underperform” rating to a “market perform” rating and boosted their price objective for the company from $27.00 to $34.00 in a research report on Wednesday, April 10th. Stephens upped their price target on shares of EQT from $46.00 to $47.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 24th. TD Cowen assumed coverage on shares of EQT in a report on Friday, April 19th. They set a “hold” rating and a $43.00 price target for the company. Finally, Mizuho upped their price target on shares of EQT from $43.00 to $45.00 and gave the stock a “neutral” rating in a report on Monday, May 13th.
Insider Buying and Selling at EQT
Hedge Funds Weigh In On EQT
Institutional investors and hedge funds have recently made changes to their positions in the stock. Private Wealth Management Group LLC bought a new position in shares of EQT during the 4th quarter worth about $30,000. BKM Wealth Management LLC bought a new position in shares of EQT during the 4th quarter worth about $40,000. Principal Securities Inc. bought a new position in shares of EQT during the 4th quarter worth about $51,000. EntryPoint Capital LLC acquired a new stake in shares of EQT in the 1st quarter worth about $54,000. Finally, Massmutual Trust Co. FSB ADV raised its holdings in shares of EQT by 52.6% in the 4th quarter. Massmutual Trust Co. FSB ADV now owns 1,563 shares of the oil and gas producer’s stock worth $60,000 after acquiring an additional 539 shares during the last quarter. Institutional investors own 90.81% of the company’s stock.
EQT Stock Down 2.0 %
Shares of EQT opened at $36.99 on Friday. EQT has a one year low of $32.07 and a one year high of $45.23. The company has a market cap of $16.33 billion, a P/E ratio of 26.80 and a beta of 1.06. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.88 and a quick ratio of 0.88. The firm has a 50 day simple moving average of $39.72 and a two-hundred day simple moving average of $37.61.
EQT (NYSE:EQT – Get Free Report) last announced its quarterly earnings data on Tuesday, April 23rd. The oil and gas producer reported $0.82 EPS for the quarter, beating the consensus estimate of $0.65 by $0.17. EQT had a net margin of 10.96% and a return on equity of 4.57%. The business had revenue of $1.30 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same period in the previous year, the business earned $1.70 earnings per share. The company’s revenue was down 28.8% on a year-over-year basis. Research analysts forecast that EQT will post 1.03 EPS for the current fiscal year.
EQT Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Saturday, June 1st. Shareholders of record on Wednesday, May 8th were given a dividend of $0.1575 per share. The ex-dividend date was Tuesday, May 7th. This represents a $0.63 dividend on an annualized basis and a yield of 1.70%. EQT’s dividend payout ratio (DPR) is currently 45.65%.
EQT Company Profile
EQT Corporation operates as a natural gas production company in the United States. The company sells natural gas and natural gas liquids to marketers, utilities, and industrial customers through pipelines located in the Appalachian Basin. It also offers marketing services and contractual pipeline capacity management services.
Featured Stories
- Five stocks we like better than EQT
- Consumer Discretionary Stocks Explained
- Sarepta Therapeutics Stock Soars on FDA Approval
- ETF Screener: Uses and Step-by-Step Guide
- CarMax: A Market Melt-Up Waiting to Happen for this Stock
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 Solar Stocks to Watch that are Building the Green Energy Future
Receive News & Ratings for EQT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EQT and related companies with MarketBeat.com's FREE daily email newsletter.